Botulinum toxin-type A: could it be an effective treatment option in intractable trigeminal neuralgia?

@inproceedings{Shehata2013BotulinumTA,
  title={Botulinum toxin-type A: could it be an effective treatment option in intractable trigeminal neuralgia?},
  author={Hatem Samir Shehata and Mohamed Soliman El-Tamawy and Nevin M. Shalaby and Gihan Ramzy},
  booktitle={The Journal of Headache and Pain},
  year={2013}
}
Botulinum toxin type A (BTX-A) has been reported to have analgesic effects independent of its action on muscle tone, mostly by acting on neurogenic inflammatory mediators and controlling the neurotransmitter release of sensory and autonomic nerve terminals that are involved in many chronic painful conditions as chronic intractable trigeminal neuralgia (TN). The aim of our work was evaluating the efficacy, safety, and tolerability of BTX-A for the treatment of intractable idiopathic TN. This was… CONTINUE READING